Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
IGF2BP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LIPA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
PBXIP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC41A2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TSPAN32 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HDDC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BANK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC44A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBE3A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SULF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRIM33 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC15A2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NMD3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VTI1A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPP30 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRIM8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SKIL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on